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ABSTRACT
Psoriasis (Ps) is the most common chronic autoimmune disease in the United States. The
immune system releases proinflammatory cytokines and growth factors that accelerate the
growth of skin cells which accumulate and form thick red patches of skin on various parts of the
body. About 25 percent of psoriasis patients develop inflammatory arthritis in which
inflammation progresses to joints and entheses.

Psoriatic Arthritis (PsA) patients exhibit joint

pain, stiffness, and swelling which can affect any part of the body. PsA occurs when the immune
cells release cytokines that act on healthy cells and tissues to induce skin and joint inflammation.
Genetic and environmental factors interact to trigger the cellular pathways that promote skin and
joint disease.
Research studies on the pathophysiology of psoriatic arthritis have revealed that alterations in
both immune cells and resident cells in the skin and joint characterize this disease. Dr.
Christopher Ritchlin’s research focuses on the links between skin and joint inflammation. His
laboratory is examining the mechanisms of bone resorption and formation, the effect of anti-TNF
agents on dendritic cell differentiation, and the mechanisms of bone marrow edema (a finding on
MRI of the joints) observed in PsA and rheumatoid arthritis.
His current research demonstrates a mechanism for the destructive pathology in psoriatic joints.
The purpose of my thesis is to illustrate Dr. Ritchlin’s research. It will be a 2-dimensional
animation explaining normal bone remodeling and the bi-directional attack on PsA joints.
Accompanying the animation is a voice over explaining what is happening on screen.
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INTRODUCTION
I chose this topic for my thesis for personal reasons. As a person suffering from psoriasis, I have
a twenty percent chance of developing psoriatic arthritis. I was not even aware of this disease
until speaking with Dr. Ritchlin. After speaking to rheumatology patients, I was informed they
do not understand what is happening within their bodies. I hope that this animation will educate
patients with high school science knowledge.
After viewing the animation, the learner will be able to:
1. State what psoriasis is
2. List the symptoms of psoriatic arthritis
3. State the events of normal bone remodeling
4. State the events of the outside-in mechanism
5. State the events of the inside-out mechanism
I contemplated creating a traditional print piece rather than an animation. This is a complex
subject and I believe an animation is easier to explain it. With an animation I am able to show
several steps without overwhelming the viewer. The labels used are large but because they
disappear, they do not crowd the image plane. The voice over also helps to reiterate ideas that
are being shown on the screen. The script explains step-by-step what is happening with in the
animation.
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WHAT IS ARTHRITIS?
Arthritis literally means “joint inflammation” and describes over 100 conditions affecting joints
and their surrounding tissues. Because the term does not describe the cause or type of joint
inflammation, it is qualified with an adjective such as rheumatoid, osteo-, or psoriatic (Scott,
1980). Arthritis also involves the degradation of cartilage, which protects the joint and allows it
to move smoothly. Without the cartilage, the bones rub together causing inflammation and
stiffness. The two most common types of arthritis are osteoarthritis and rheumatoid arthritis
(RA). Osteoarthritis causes pain, stiffness and inflammation most often in the hips, knees and
hands, while rheumatoid arthritis usually affects the hands and wrists. People suffering from
these two diseases often exhibit stiffness, swelling, and pain in the joints.
WHAT IS PSORIASIS?
Psoriasis is a chronic inflammatory skin disease that affects up to 3% of the population (Menter
et. al., 2008). There are several forms including chronic plaque psoriasis, erythrodermic
psoriasis, pustular psoriasis, inverse psoriasis and gluttate psoriasis. Chronic plaque psoriasis
(psoriasis vulgaris) is the most common type and is present in over 90% of patients with
psoriasis. There are two types of chronic plaque psoriasis:
Type I: occurs in adolescents with a family history of psoriasis and is the most
common type.
Type II: manifests in patients between 50 and 60 years of age with no family history.
Psoriasis most commonly affects the scalp, nails, extensor surfaces of limbs, elbows, knees,
umbilicus, genital, and sacral regions. The major characteristics of psoriasis are scaling,
thickening and inflammation.
Psoriasis occurs when the immune system sends out faulty signals that tell the skin to grow
quickly, forming thick red patches of skin (Scott, 2012). This is a chronic autoimmune disease
that is not contagious. There are several triggers that cause psoriasis to flare: trauma, infections,
stress, medications, alcohol, smoking, obesity and estrogen (Menter et. al., 2008).
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WHAT IS PSORIATIC ARTHRITIS?
Psoriatic arthritis is an inflammatory autoimmune joint disease distinguished by extensive bone
resorption (Ritchlin et. al., 2003). The body attacks its own tissues and sends white blood cells
to the synovium eventually inflaming the tissue. The inflammation causes the synovium to
thicken which results in a swollen joint. As the synovium continues to thicken into the pannus, it
begins to invade the cartilage, which then begins to erode. This causes bones to rub together
causing joint damage (Ludlam, 2012). Joint damage occurs early in the disease so early
diagnosis is important.
About twenty percent of people suffering from psoriasis develop psoriatic arthritis. In seventy
five percent of cases, psoriasis precedes PsA. Psoriatic arthritis generally goes undiagnosed and
untreated and is often confused with rheumatoid arthritis. According to Ritchlin, there are
several musculoskeletal features that characterize PsA: tendonitis, enthesitis, dactylitis, and
arthritis (2007). There are also five clinical patterns of PsA for classification (Menter et. al.,
2008):
1. Distal arthritis
2. Asymmetric oligoarthritis
3. Symmetric polyarthritis
4. Arthritis with axial disease
5. Arthritis mutilans
The most commonly affected joints are the spine and distal interphalangeal joints (DIP joints) of
the hands and feet. Involvement of the DIP joints is common in patients with nail disease
(Menter et. al., 2008). The rheumatoid factor (an antibody) is present in 80% of patients with
RA and up to 10% of patients with PsA making the two diseases hard to distinguish. RA is more
common in women and involves symmetrical joint inflammation. PsA affects men and women
equally and all joints of a single digit are affected, specifically the DIP joints. PsA joints are less
erythematous, less tender, and more fibrous. Enthesistis is also present in PsA patients.
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There are five types of psoriatic arthritis (Levesque, 2010):
1. Symmetric: affects the same joints on both sides of the body; milder than rheumatoid
arthritis
2. Asymmetric: affects one to three joints in the body; non-matching pairs
3. Distal interphalangeal predominant: affects the small joints in fingers and toes closest
to the nail
4. Spondylitis: affects the spinal column and may cause stiffness in the neck, lower
back, spinal vertebrae, or pelvic region; may also attach ligaments
5. Arthritis mutilans: severe and destructive form of PsA that affects the small joints in
the fingers and toes and also the lower back and neck; very uncommon
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DR. RITCHLIN’S RESEARCH
Dr. Christopher Ritchlin of the University of Rochester Medical Center has focused his research
on understanding the mechanisms of pathologic bone resorption and new bone formation in both
psoriatic arthritis and rheumatoid arthritis. His lab is also working with Dr. Eddie Schwarz (also
of URMC) to understand the mechanisms of bone marrow edema that shows on MRI images of
inflammatory arthritis. Dr. Ritchlin is also performing studies on the effect of tumor necrosis
factor (TNF) inhibition on the frequency of osteoclast precursors and enhancing bone marrow
edema in PsA.
There are four types of cells that make up bone: osteoprogenitor cells, osteoblasts, osteoclasts
and osteocytes. Osteoprogenitor cells (OPCs) are immature cells located in bone marrow and the
periosteum that mature into osteoblasts. Osteoblasts are bone cells responsible for bone
formation. Osteoclasts are responsible for the breakdown of the bone matrix. Osteocytes are
mature bone cells.
Bone remodeling is the process of bone matrix breakdown by osteoclasts. Osteoclasts attach to
the bone surface and form a leak-proof seal at the edges with their ruffled border. They release
protein digesting lysosomal enzymes and acids. The enzymes digest collagen fibers and the acid
digests bone mineral. Several osteoclasts carve out a tunnel and degraded proteins and matrix
minerals enter the osteoclast by endocytosis. Osteoclasts depart the bone and osteoblasts move
in and bone remodeling begins. Osteoblasts synthesize and secrete collagen fibers and other
matrix building tissues (Tortora, 2003).
According to Ritchlin “the presence of marked bone resorption coupled with adjacent new bone
formation (often in the same digit) suggests a disordered pattern of bone remodeling in the
psoriatic joint” (2003). The purpose of his research is to explain how osteoclast precursors
(OCPs), RANK (receptor activator of nuclear factor kappa-B), RANKL (receptor activator of
nuclear factor kappa-B ligand), and osteoprotegerin (OPG) cause osteolysis in PsA. Dr. Ritchlin
found that the number of OCPs is increased in PsA patients, but this number was not
significantly different from the number found in RA samples.
The results of this study propose a bi-directional attack on the joints, known as the “inside-out”
and “outside-in” mechanisms. First, TNF-α increases the number of circulating OCPs. In the
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inside-out mechanism osteoclast precursors enter the synovial membrane from the bone marrow
and migrate to the site of inflammation. High levels of osteoprotegerin expressed by endothelial
cells suppress osteoclastogenesis. Undifferentiated osteoclast precursors migrate through the
pannus and target the bone. At the bone-pannus junction, osteoclast precursors bind to RANKL
on the surface of synoviocytes. In the presence of TNF-α, osteoclast precursors undergo
osteoclastogenesis and become osteoclasts. The osteoclasts then begin bone remodeling.
In the outside-in mechanism of bone remodeling osteoclast precursors enter the subchondral
environment via the periosteal vessels from the inflamed synovial tissue. The osteoclast
precursors translocate through the endothelium of the blood vessels. They are then exposed to
TNF-α induced RANKL on the surfaces of osteoblasts and stromal cells. This exposure causes
generation of osteoclasts that line cutting cones devoid of synovial tissue. The mature
osteoclasts resorb bone matrix in the subchondral bone and at the pannus-bone interface
(Ritchlin, 2003).
In normal bone remodeling, lining cells along the bone matrix differentiate into osteoblasts. The
osteoblasts move apart to expose the bone surface and begin to express RANKL. RANKL binds
to RANK located on osteoclast precursor cells, which are derived from monocytes. Multiple
osteoclast precursors fuse to form multi-nucleated osteoclasts. RANKL continues to bind to
RANK on mature osteoclasts. Osteoclasts move to the bone surface and form a leak proof seal
with their ruffled border. They begin to excrete enzymes and acids, which break down the bone
matrix resulting in the formation of deep pits. Osteoclasts then leave the bone to allow
osteoblasts to move in and fill the pits with new bone matrix.
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PROCESS
After deciding on the subject of arthritis I contacted several rheumatologists in the Rochester
area. Dr. Christopher Ritchlin responded to me with enthusiasm. I met with him, discussed his
research, and began brainstorming ideas. After reading his article titled “Mechanisms of TNF-α
and RANKL-mediated osteoclastogensis and bone resorption in psoriatic arthritis” I decided on
animating this process (Ritchlin, 2003). He uses the following image in his article:

To me, this image is very confusing. When I first looked at it I felt overwhelmed by everything
depicted. Although patients ultimately may not fully understand his research, I feel they should
be educated on what is happening in their bodies, and I believe this animation will do that.
Using this article and image as my main source, I began to decipher the different components of
the synovial joint and osteoclastogenesis. I determined the animation should consist of four
parts: introduction, normal bone remodeling, outside-in mechanism, and inside-out mechanism.
I think it is imperative for the viewer to understand normal bone remodeling to ultimately
understand what happens during bone remodeling within a person suffering from PsA. I
researched bone remodeling extensively in order to fully understand the different cells involved
in the process and what happens to joints.
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I began to illustrate osteoclasts, osteoblasts, and RANKL using different programs because I was
not sure if I wanted to create a 2D or 3D animation. I was always leaning toward a 2D animation
due to my knowledge of these programs, but I found several 3D animations online that were very
nice. I made the cells in Photoshop, Illustrator and Maya, because I was not sure which way I
was going to go.

Osteoclasts

Adobe Photoshop

Adobe Illustrator

Autodesk Maya

Osteoblasts

Adobe Photoshop

Adobe Illustrator

Autodesk Maya

RANK

Adobe Photoshop

Adobe Illustrator
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During the beginning of my process, I experimented with all three of these programs, trying to
determine which one would ultimately be best to create my animation. I began watching
tutorials on Maya and After Effects on Lynda.com. I knew if I wanted to create a twodimensional animation it would need to be done in After Effects rather than Flash, so it would
display on Apple products. Tablets, especially the iPad, have become more popular for both
personal and professional use, and I want viewers to be able to use their tablet to view my
animation. Another determining factor for the type of animation was time. Although I have
used Maya to model, I had never used it to animate. I did not feel as though I had enough time to
learn this in order to create a successful piece. I felt much more comfortable with using After
Effects and that my time would be used more wisely.
Once I decided on the animation program, I began to draw storyboards. During most of my
thesis I created and re-created storyboards to determine the best way to execute this animation.
Once I came up with a general idea of what I wanted to create, I began to experiment in After
Effects. I imported .psd files (from Photoshop) and began to animate the osteoblasts moving, but
because they are raster images, things became pixelated. That is what finally led me to use only
Illustrator files within the animation (moving objects only) and use Photoshop for the static
images. I created the figure, hand, and x-ray images using Poser and Photoshop, and the
trabeculae and synovial joint using only Photoshop.

Trabeculae static image
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Synovial joint static image

Screen Shot: Introduction
I knew that in order for viewers to understand what was happening within this animation, I
needed labels and a voice over. For the labels I decided that each time a new cell appears on the
screen it would have a label. Because this animation is geared toward an audience with high
school science knowledge, I thought these labels would help explain things better.
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Screen Shot: Normal bone remodeling with label
Throughout the illustration process I was also working on a script (see Appendix). After
thoroughly reading and re-reading Dr. Ritchlin’s research, I was able to write the process of bone
remodeling in a way for viewers with high school science knowledge to understand. I sent the
script to Dr. Ritchlin for final approval. After receiving edits from him, I recorded trial sounds
and began working on the animation. I did not record the final voice over until late into my
process, which was a mistake. I found that it was much easier to animate with the finished voice
over due to timing. If I had to do this again, I would write and record the script before
animating.
There is also background music accompanying the voice over. After viewing other medical
animations online, I found that the ones with both a voice over and background music were most
pleasing.
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CONCLUSION
This animation has taught me several lessons as a medical illustrator. I have expanded my
knowledge of rheumatology and learned about a disease that I knew nothing about. My abilities
as a two-dimensional animator have improved to the point that I am now able to envision
animation opportunities that I had previously not considered. I now have a better understanding
for the entire animation process as well.
This animation explains the concept of Dr. Ritchlin’s work in a simple way. I hope that he can
use this piece for patient education and to generate public knowledge of this disease. I would
love to continue working with him as his research progresses and elaborate the animation.
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APPENDIX
Voice over script
Psoriasis is an autoimmune disease that results in inflammatory cell infiltration in the deeper
layers of the skin, which promotes rapid growth of cells in the superficial layers. This results in
the formation of red, scaly plaques. It is thought to be sustained by faulty signals that speed up
the growth of skin cells.
About twenty percent of patients with psoriasis develop psoriatic arthritis.
Psoriatic arthritis is an inflammatory musculoskeletal disease that causes pain, stiffness, and
swelling at the joints. Psoriatic arthritis can affect the lower back, wrists, and ankles but
typically causes dactylitis, or swelling, of the fingers and toes.
Bone remodeling is a key factor in damage that is observed in the joints and x-rays of patients
with psoriatic arthritis.
In normal bone remodeling, lining cells along the bone matrix differentiate into osteoblasts. The
osteoblasts move apart to expose the bone surface and begin to express RANKL. RANKL binds
to RANK located on osteoclast precursor cells, cells which are derived from monocytes.
Multiple osteoclast precursors fuse to form multi-nucleated osteoclasts. RANKL continues to
bind to RANK on mature osteoclasts. Osteoclasts move to the bone surface and form a leak
proof seal with their ruffled border. They begin to excrete enzymes and acids, which break down
the bone matrix resulting in the formation of deep pits. Osteoclasts then leave the bone to allow
osteoblasts to move in and fill the pits with new bone matrix.
Joint erosion in psoriatic arthritis is caused by a bi-directional attack on the joint. There are two
mechanisms for this attack: outside-in and inside-out.
In the outside-in mechanism of bone remodeling osteoclast precursors enter the subchondral
environment via the periosteal vessels. The osteoclast precursors translocate through the
endothelium of the blood vessels. They are then exposed to TNF-α induced RANKL on the
surfaces of osteoblasts and stromal cells. This exposure causes generation of osteoclasts that line
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cutting cones devoid of synovial tissue. The mature osteoclasts resorb bone matrix in the
subchondral bone and at the pannus-bone interface.
In the inside-out mechanism osteoclast precursors enter the synovial membrane from the bone
marrow and migrate to the site of inflammation. High levels of
Osteoprotegerin expressed by endothelial cells suppress osteoclastogenesis. Undifferentiated
osteoclast precursors migrate through the pannus and target the bone. At the bone-pannus
junction, osteoclast precursors bind to RANKL on the surface of synoviocytes. In the presence
of TNF-α, osteoclast precursors undergo osteoclastogenesis and become osteoclasts. The
osteoclasts then begin bone remodeling.
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GLOSSARY
Cutting cone
Groups of osteoclasts that attach to bare bone surfaces and dissolve the organic and
inorganic matter
Osteoblast
Bone-building cell
Osteocyte
Cell that makes up bone tissue
Osteoclast
Cell responsible for the breakdown of bone matrix
Osteoclastogenesis
The development of osteoclasts
Osteoprogenitor cell
Immature cells located in the bone marrow that mature into osteoblasts
Osteoprotegerin
A cytokine that inhibits osteoclastogenesis
Pannus
Thickened synovial tissue that covers cartilage
RANK
Receptor activator of nuclear factor kappa B; a protein expressed on the surface of
osteoclasts
RANKL
Receptor activator of nuclear factor kappa B Ligand; found on osteoblasts and activate
osteoclasts
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Rheumatoid factor
The antibody most prevalent in rheumatoid arthritis
Subchondral bone
Bone located below the articular cartilage
Synoviocyte
Cell of the synovium
TNF-α
Tumor necrosis factor; a cytokine involved in systemic inflammation
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